BioSeek, Drug Discovery Through Human Biology

Welcome to Asterand!

We would like to welcome BioSeek customers, partners and employees to Asterand. This highly complementary acquisition will bring a broad array of products and services to all of our drug discovery clients.

BioSeek's BioMap^® Systems will bring a unique and scalable platform to Asterand's product and service line. We are looking forward to bringing these two highly creative and quality-driven teams together to expand and grow the business!

BioSeek, Inc. is now BioSeek LLC,
a wholly-owned subsidiary of Asterand plc

To find out more about Asterand click here

News & Events

March 3, 2010
Notification of Preliminary Results

February 18, 2010
Asterand Completes Acquisition of BioSeek

November 18, 2009
Asterand Announces Agreement to Acquire BioSeek

June 30, 2009
BioSeek and EPA Expand ToxCast™ Contract

June 10, 2009
BioSeek and Merck Serono Extend 2008 Agreement - Compound Profiling Collaboration Continues into 2012

January 7, 2009
BioSeek and UCB Establish New Compound Evaluation Collaboration, Expand Previous Agreement.

November 13, 2008
BioSeek Licenses Two Novel Anti-Inflammatory Peptides.

August 22, 2008
BioSeek enters into a one-year collaboration agreement with Solvay Pharmaceuticals.

May 20, 2008
BioSeek to Collaborate with Merck Serono to Assess Potential Drug Candidates.

BioMAP^® Systems are integrated cell systems that generate a unique signature of human biological response for prediction of mechanisms and therapeutic efficacy. More...